SwedenBIO CEO Summit Dec. 3rd 2009, Berns Salonger in Stockholm

Anders Ekblom Executive Vice President Global Drug Development AstraZeneca and Member of the Innovation and Growth Project will let us know how innovation can give growth to industry and society.
Hear Jonathan Knowles give his visions for 2015 for Swedish Life Science. Mr Knowles is Head of Group Research and Member of the Executive Committee at Roche, Board Member of Chugai and is former Board Member of Genentech.
Tobias Marguerre General Manager Octapharma AB/Octapharma Nordic AB will give his view on long-term investments for expansion in Sweden.

The Center Director of Swedish Medical Nanoscience Center,
Agneta Richter-Dahlfors, will let us know if it is possible synchronize interdisciplinary life science with industrial needs.
Mikko Alkio, former state secretary in Finland and Head of Group Research at Roschier, played a central role in the preparations of the national innovation strategy in Finland in 2008.

Charlotte Brogren, General Director VINNOVA will give us her view how VINNOVA can be a catalyst for the industry’s R&D today and in 2015.
What does the industry need to reach their goals in the future? Nils Bohlin, partner at Arthur D. Little, will present SwedenBIOs Industry Survey 2009.

Welcome from 14.30 until 18.45, with networking afterwards

For registration and programme, please visit: http://www.swedenbio.com/ceosummit2009

Welcome!

Main sponsor: Octapharma

Professional Partners: Bird & Bird, Groth & Co, Merck and PriceWaterhouseCoopers

Partners: Stockholm Science City Foundation, Stockholm Uppsala Life Science and Uppsala BIO

Media Partner: Veckans Affärer

Official Member Magazine: BiotechSweden

For more information and questions please contact:

Maria Kaaman, Project Manager Communications SwedenBIO
08- 21 31 32, 0730489034 or by e-mail: maria.kaaman@swedenbio.com
or
Mats Berggren, CEO SwedenBIO
08- 21 36 01, 0708714773 or by e-mail: mats.berggren@swedenbio.com